title: ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.
abstract: The recently isolated second family of neuregulins, NRG2, shares its primary receptors, ErbB-3 and ErbB-4, and induction of mammary cell differentiation with NRG1 isoforms, suggesting functional redundancy of the two growth factor families. To address this possibility, we analyzed receptor specificity of NRGs by using an engineered cellular system. The activity of isoform-specific but partly overlapping patterns of specificities that collectively activate all eight ligand-stimulatable ErbB dimers was revealed. Specifically, NRG2-alpha [corrected], like NRG1-beta [corrected], emerges as a narrow-specificity ligand, whereas NRG2-beta [corrected] is a pan-ErbB ligand that binds with different affinities to all receptor combinations, including those containing ErbB-1, but excluding homodimers of ErbB-2. The latter protein, however, displayed cooperativity with the direct NRG receptors. Apparently, signaling by all NRGs is funneled through the mitogen-activated protein kinase (MAPK). However, the duration and potency of MAPK activation depend on the identity of the stimulatory ligand-receptor ternary complex. We conclude that the NRG-ErbB network represents a complex and nonredundant machinery developed for fine-tuning of signal transduction.
authors.affiliation: Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel.
authors.forename: R
authors.initials: R
authors.lastname: Pinkas-Kramarski
authors.forename: M
authors.initials: M
authors.lastname: Shelly
authors.forename: B C
authors.initials: BC
authors.lastname: Guarino
authors.forename: L M
authors.initials: LM
authors.lastname: Wang
authors.forename: L
authors.initials: L
authors.lastname: Lyass
authors.forename: I
authors.initials: I
authors.lastname: Alroy
authors.forename: M
authors.initials: M
authors.lastname: Alimandi
authors.forename: A
authors.initials: A
authors.lastname: Kuo
authors.forename: J D
authors.initials: JD
authors.lastname: Moyer
authors.forename: S
authors.initials: S
authors.lastname: Lavi
authors.forename: M
authors.initials: M
authors.lastname: Eisenstein
authors.forename: B J
authors.initials: BJ
authors.lastname: Ratzkin
authors.forename: R
authors.initials: R
authors.lastname: Seger
authors.forename: S S
authors.initials: SS
authors.lastname: Bacus
authors.forename: J H
authors.initials: JH
authors.lastname: Pierce
authors.forename: G C
authors.initials: GC
authors.lastname: Andrews
authors.forename: Y
authors.initials: Y
authors.lastname: Yarden
authors.forename: M
authors.initials: M
authors.lastname: Alamandi
mesh_terms: D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism; D002460:Cell Line; D004789:Enzyme Activation; D066246:ErbB Receptors / Q000096:biosynthesis / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism* / Q000494:pharmacology; D007536:Isomerism; D008024:Ligands; D009414:Nerve Growth Factors / Q000378:metabolism* / Q000494:pharmacology; D020880:Neuregulins; D010766:Phosphorylation; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000378:metabolism*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis / Q000378:metabolism*; D020893:Receptor, ErbB-3; D066247:Receptor, ErbB-4
chemical_list: D017871:Calcium-Calmodulin-Dependent Protein Kinases; D066246:ErbB Receptors; D006023:Glycoproteins; D008024:Ligands; D009414:Nerve Growth Factors; D020880:Neuregulins; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D020893:Receptor, ErbB-3; D066247:Receptor, ErbB-4; C106766:NRG2 protein, human; C587689:ERBB4 protein, human